Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...
Yazar: | Anderson, R |
---|---|
Diğer Yazarlar: | Vallis, K |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2021
|
Konular: |
Benzer Materyaller
-
Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
Yazar:: REN Ya'nan, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
Yazar:: Solmaz Mojarad-Jabali, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
Yazar:: P. August Schubiger, ve diğerleri
Baskı/Yayın Bilgisi: (2004-10-01) -
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
Yazar:: Paweł Szponar, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01) -
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
Yazar:: Alessio Rizzo, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)